Q2 Results interview

Overview (AW)	01:23
Declining “headwinds” (AW)	01:15
Emerging markets (AW)	02:15
Financial strategy and efficiencies (SD)	02:59
Margin improvements (SD)	01:19
R&D strategy and delivery (AW)	03:22
Drug discovery review (AW)	03:19

Andrew Witty, Simon Dingemans,

CEO CFO

GlaxoSmithKline

Do more, feel better, live longer

The World of GSK 2010 Corporate reporting 2010 CR Report

Useful links

GSK Results Interview 26/07/2011 Andrew Witty and Simon Dingemans